Cancer nanovaccine plus doxorubicin and immune checkpoint blockade overcomes chemoresistance and delays postsurgical recurrence.
Journal: Journal of nanobiotechnology
•
Abstract
Abstract text is not embedded in this discovery record. Please consult the full-text publication via the source link on the right.
Subjects & Keywords
How to Cite this Article
Lee CM, Kwon YK, Won JE, et al. (2026). "Cancer nanovaccine plus doxorubicin and immune checkpoint blockade overcomes chemoresistance and delays postsurgical recurrence.". Journal of nanobiotechnology. https://doi.org/10.1186/s12951-026-04892-3